These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 7758352)

  • 1. Autoantibodies in IgA nephropathy.
    O'Donoghue DJ; Feehally J
    Contrib Nephrol; 1995; 111():93-103; discussion 104-6. PubMed ID: 7758352
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunopathogenesis of IgA nephropathy--new data based on the clinical and experimental studies].
    Krzymański M
    Przegl Lek; 1992; 49(1-2):13-5. PubMed ID: 1454998
    [No Abstract]   [Full Text] [Related]  

  • 3. [IGA nephropathy].
    Siciński A
    Pol Arch Med Wewn; 1987 Dec; 78(6):363-7. PubMed ID: 3270810
    [No Abstract]   [Full Text] [Related]  

  • 4. Mesangial autoantigens in IgA nephropathy: matrix synthesis and localization.
    Darvill AM; Ballardie FW
    J Lab Clin Med; 2006 Jun; 147(6):301-9. PubMed ID: 16750668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial cell antigens recognized by IgA autoantibodies in patients with IgA nephropathy: partial characterization.
    Wang MX; Walker RG; Kincaid-Smith P
    Nephrol Dial Transplant; 1992; 7(8):805-10. PubMed ID: 1325612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune regulation in IgA nephropathy.
    Monteiro RC; Noël LH; Chevailler A; Halbwachs-Mecarelli L; Lesavre P
    Nephrologie; 1989; 10(3):147-50. PubMed ID: 2691912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycosylation of IgA1 and pathogenesis of IgA nephropathy.
    Novak J; Julian BA; Mestecky J; Renfrow MB
    Semin Immunopathol; 2012 May; 34(3):365-82. PubMed ID: 22434325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uteroglobin is essential in preventing immunoglobulin A nephropathy in mice.
    Zheng F; Kundu GC; Zhang Z; Ward J; DeMayo F; Mukherjee AB
    Nat Med; 1999 Sep; 5(9):1018-25. PubMed ID: 10470078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum IgA and macromolecular IgA reacting with mesangial matrix components.
    Coppo R; Amore A; Gianoglio B; Reyna A; Peruzzi L; Roccatello D; Alessi D; Sena LM
    Contrib Nephrol; 1993; 104():162-71. PubMed ID: 8325027
    [No Abstract]   [Full Text] [Related]  

  • 10. Underglycosylation of IgA in IgA nephropathy: more than a diagnostic marker?
    Roos A; van Kooten C
    Kidney Int; 2007 Jun; 71(11):1089-91. PubMed ID: 17522695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the mechanism producing solubilization of immune precipitates in the serum of patients with primary IgA nephropathy.
    Schena FP; Pastore A; Sinico RA; Ladisa N; Montinaro V; Fornasieri A
    Semin Nephrol; 1987 Dec; 7(4):336-40. PubMed ID: 3445011
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy in IgA nephropathy--when and how to do it].
    Vas T; Kovács T; Késoi I; Sági B; Degrell P; Wittmann I; Nagy J
    Orv Hetil; 2011 Dec; 152(51):2039-46. PubMed ID: 22130201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-mesangial and anti-endothelial cell antibodies in IgA mesangial nephropathy.
    Fornasieri A; Pinerolo C; Bernasconi P; Li M; Armelloni S; Gibelli A; D'Amico G
    Clin Nephrol; 1995 Aug; 44(2):71-9. PubMed ID: 8529312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180.
    Kromminga A; Scheckenbach C; Georgi M; Hagel C; Arndt R; Christophers E; Bröcker EB; Zillikens D
    J Autoimmun; 2000 Nov; 15(3):293-300. PubMed ID: 11040070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopathogenetic aspects of IgA nephropathy.
    van den Wall Bake AW; Daha MR; van Es LA
    Nephrologie; 1989; 10(3):141-5. PubMed ID: 2691911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent immunologic data on human glomerulonephritis.
    Lesavre P; Monteiro RC; Chevailler A; Berger J; Halbwachs-Mecarelli L; Noël LH
    Adv Nephrol Necker Hosp; 1988; 17():57-75. PubMed ID: 3124552
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanisms of IgA deposition in the mesangium.
    van den Wall Bake AW
    Contrib Nephrol; 1993; 104():138-46. PubMed ID: 8325024
    [No Abstract]   [Full Text] [Related]  

  • 18. Macromolecular IgA in the circulation and mesangial deposits in patients with primary IgA nephropathy.
    Valentijn RM; Radl J; Haayman JJ; Vermeer BJ; Weening JJ; Kauffmann RH; Daha MR; van Es LA
    Contrib Nephrol; 1984; 40():87-92. PubMed ID: 6499467
    [No Abstract]   [Full Text] [Related]  

  • 19. New insights in the pathogenesis of IgA nephropathy.
    Monteiro RC
    Nefrologia; 2005; 25 Suppl 2():82-6. PubMed ID: 16050408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological studies of experimental IgA nephropathy in mice.
    Gonzalez E; Egido J; Gonzalez-Cabrero J; Sancho J; Blasco R; Garcia-Hoyo R; Lozano L; Barat A
    Adv Exp Med Biol; 1987; 216B():1583-91. PubMed ID: 3425449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.